BALTIMORE, March 2,
2023 /PRNewswire/ -- Medifast (NYSE: MED), the global
company behind one of the fastest-growing health and wellness
communities, OPTAVIA®, today announced it has named
Steven Zenker as Vice President of
Investor Relations.
Mr. Zenker has over 30 years of investor relations, financial
planning and analysis, communications, and investment management
experience. He reports to Chief Financial Officer Jim Maloney and will lead the strategy and
continued implementation of the company's investor relations
program.
"We are pleased to welcome Steven to the Medifast team and look
forward to his leadership as we continue to shape our investor
relations program for long-term success. His strong track record of
financial leadership and expertise in both investor relations and
corporate communications are invaluable to continuing to
communicate Medifast's unique business model and our opportunities
ahead," said Jim Maloney, Chief
Financial Officer of Medifast. "We are focused on creating a
stronger connection with the financial community, deepening
engagement with those who already know us and attracting others new
to the Medifast story."
Most recently, Mr. Zenker served as Senior Vice President and
Vice President of Investor Relations at Sinclair Broadcast Group,
where he led the development and implementation of the company's
investor relations strategy. Prior to joining Sinclair, Mr. Zenker
was Vice President of Investor Relations, FP&A and Corporate
Communications for Central Garden & Pet Company, where he
worked for nine years. From 2007 to 2011, he was Senior Vice
President & Portfolio Manager for Bank of America Private
Wealth Management. Prior to that role, starting in 2002, he was
Vice President of Investor & Corporate Communications for WCI
Communities, Inc. In addition, Mr. Zenker held portfolio manager
and investment analyst positions for several buy-side investment
firms.
Mr. Zenker received his bachelor's degree in business
administration from SUNY Albany and his
master's degree in business administration from Fordham University.
"Medifast is uniquely positioned to help people achieve optimal
health and wellbeing, with a business model that is compelling for
stockholders. I look forward to further communicating the
investment thesis and advancing the efforts already underway as
Medifast evolves its business and works toward long-term growth
targets," said Steven Zenker.
About Medifast:
Medifast (NYSE: MED) is the global company behind one of
the fastest-growing health and wellness
communities, OPTAVIA®, which offers scientifically
developed products, clinically proven plans and the support of
independent OPTAVIA Coaches and a Community to help
Customers achieve Lifelong Transformation, One Healthy Habit at a
Time®. As the publicly traded market leader by revenue in the
U.S. $7 billion weight management industry, the company
has impacted more than 2 million lives through its Community
of OPTAVIA Coaches, who teach Customers how to develop
holistic healthy habits through the proprietary Habits of Health®
Transformational System. Medifast was recognized in 2022 as one
of America's Best Mid-Sized Companies by Forbes, in 2020 and
2021 as one of FORTUNE's 100 Fastest-Growing
Companies and was named to Forbes' 100 Most Trustworthy
Companies in America list in 2017. For more information,
visit MedifastInc.com or OPTAVIA.com and
follow @Medifast on Twitter.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medifast-appoints-steven-zenker-as-vice-president-of-investor-relations-301760098.html
SOURCE Medifast